The number of PMS targets will not be arbitrarily enlarged by pharmaceutical companies
It seems that the number of targets for PMS(Post-Marketing Surveillance)-targeted pharmaceutical products will not be arbitrarily enlarged by pharmaceutical companies.
On the 22nd, the Ministry of Food and Drug Safety gave the administrative notice of the Partial Amendment for the ‘New Drug Reev...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
